AmBisome
· Published by Health Canada · Official notice
Alert type: Drug Recall
Category: Drugs
Issue: Product Safety
Audience: General Public, Healthcare Professionals, Hospitals
Department: Health Canada
Hazard classification: Type I
| Lot or serial number | Companies | Brand name | Dosage form | DIN, NPN, DIN-HIM | Strength |
|---|
| 042269AA | - Recalling Firm
- Astellas Pharma Canada, Inc.
| A. AmBisome | Lyophilized powder | DIN 02241630 | 50mg per vial (4 mg amphotericin B/mL when constituted) |
Recalled products
-
AmBisome
Two lots of AmBisome (042269AA and 0422C1AA) may have been exposed to bacterial contaminant during the manufacturing process.
Wholesalers and hospitals in all provinces in Canada.